Meeting ReportMeeting Highlights
Report on the 9th International Congress on Peritoneal Surface Malignancies
Yan Li, Yang Yu and Yang Liu
Cancer Biology & Medicine December 2014, 11 (4) 281-284; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.04.008
Yan Li
1Hubei Cancer Clinical Study Center, Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
Yang Yu
1Hubei Cancer Clinical Study Center, Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
Yang Liu
1Hubei Cancer Clinical Study Center, Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
In this issue
Report on the 9th International Congress on Peritoneal Surface Malignancies
Yan Li, Yang Yu, Yang Liu
Cancer Biology & Medicine Dec 2014, 11 (4) 281-284; DOI: 10.7497/j.issn.2095-3941.2014.04.008
Jump to section
- Article
- The historical background and contemporary significances of recommended guidelines on PC treatment by PSOGI
- Key messages from the Amsterdam statement
- Prospective randomized clinical trials of prophylactic HIPEC for colorectal cancer patients with high risk of peritoneal metastases
- CRS + HIPEC to treat PC of ovarian origin
- The learning curve and technical training of CRS + HIPEC strategy
- Comments and future perspectives
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- No citing articles found.